Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA.
Curr Opin Support Palliat Care. 2010 Dec;4(4):276-80. doi: 10.1097/SPC.0b013e32833e48d1.
To provide an overview of issues central to hydration in an oncology population while highlighting recent advances and publications in the clinical and scientific literature.
Dehydration accounts for a significant number of unplanned visits to cancer clinics and emergency rooms. The decision to provide or withhold fluid in patients with terminal cancer is strongly influenced by subjective beliefs and the decision to use of hydration at the end of life should be individualized. Chronic dehydration may play a role in the pathogenesis of cancer.
Cancer patients are at high risk for dehydration from both the disease and the treatment. Treating physicians should have a low threshold for providing additional fluids to prevent dehydration. For patients at the end of life, hydration may be indicated in select patients.
概述肿瘤患者液体摄入相关的问题，重点介绍临床和科学文献中液体摄入的最新进展。
脱水是癌症患者到癌症诊所和急诊室就诊的重要原因。对于终末期癌症患者，是否补液主要取决于主观信念，终末期的补液治疗应该个体化。慢性脱水可能在癌症发病机制中发挥作用。
癌症患者因疾病和治疗而面临脱水的高风险。治疗医生应低门槛地为患者提供额外的液体，以预防脱水。对于终末期患者，在某些患者中可能需要补液。
Zotero 插件